ERCC1 and small cell lung carcinoma: And the result indicated that ERCC1 expression was not significantly associated with the ORR in SCLC patients receiving platinum-based chemotherapy (OR = 0.93, 95% CI = 0.61–1.41, I2 = 16.1%, P = 0.31 for heterogeneity; Table 2, Figure.